Study: Cost of treating diabetes to triple by 2034
CNN - Fri Nov 27, 1:45 am ETThe number of Americans with diabetes will nearly double in the next 25 years, and the costs of treating them will triple, according to a new report.
16309 Stories, most recent news story added 4 minutes ago
The number of Americans with diabetes will nearly double in the next 25 years, and the costs of treating them will triple, according to a new report.
The diabetes population in the United States will almost double over the next 25 years and annual medical spending on the disease is projected to hit $336 billion, up from $113 billion today, according to a study published in the December issue of Diabetes Care.
(ARA) - It's a long drive out to the rural diabetes clinic where she makes her educational presentations, but Janie Burmester knows that the work she's doing can have a huge impact on people's lives. Burmester is one of about 15,000 Certified Diabetes Educators (CDEs) in the United States.
November is National Diabetes Month and the prevalence of the disease is increasing, according to the American Diabetes Association.
WEDNESDAY, Nov. 25 (HealthDay News) -- A drug commonly used to treat non-Hodgkin's lymphoma and rheumatoid arthritis now also shows some promise in helping patients newly diagnosed with type 1 diabetes.
ALEXANDRIA, VA--(Marketwire - 11/27/09) - By 2034, the number of Americans living with diabetes will nearly double and diabetes spending will nearly triple to $336 billion, even if the prevalence of obesity in this country remains stable, according to a study published in the November issue of Diabetes Care. A team of researchers led by the University of Chicago constructed a model of diabetes ...
Rituxan, a drug used to treat cancer and rheumatoid arthritis, may help slow the development of newly discovered type 1 or juvenile diabetes, researchers reported on Wednesday.
WEDNESDAY, Nov. 25 (HealthDay News) -- Mitochondrial damage causes people with type 2 diabetes to lose insulin-producing cells, a finding that could lead to new treatments, U.S. researchers say.
GlobalData's "UK Diabetes Care Devices Market Analysis and Forecasts to 2015" report provides key data, information and analysis on the UK diabetes care devices market.
(ARA) - November is American Diabetes Month, a time to recognize the deadly disease that nearly 24 million children and adults live with today. Another 57 million people have pre-diabetes or are at risk for developing type 2 diabetes.
T-cell immune responses destroy insulin-making beta cells in type 1 diabetes -- but new studies show that targeting B cells slows beta-cell destruction and delays diabetes.